EGFR type 2 (VEGFR2 or KDR) is specifically overexpressed in ovarian cancer [120], colorectal cancer [121], breast cancer [122], etc. The peptide K237 (HTMYYHHYQHHL) has exhibited a strong binding affinity to KDR [75]. Here, KDR is linked to breast carcinoma.